Christopher A. Viehbacher has been the CEO of Biogen since November 2022, stepping in at a critical time for the company. With a strong background in healthcare, having previously served as Global CEO of Sanofi, he knows the industry well....
Christopher A. Viehbacher has been the CEO of Biogen since November 2022, stepping in at a critical time for the company. With a strong background in healthcare, having previously served as Global CEO of Sanofi, he knows the industry well. He co-founded Gurnet Point Capital and led various initiatives at Biogen when he arrived, aiming to realign the company's focus and strategy. His work has driven the launch of new therapies like LEQEMBI, helping to address significant health challenges. With a B.Comm from Queen's University and being a Chartered Accountant, Viehbacher combines business acumen with a passion for healthcare.